HealthExec February 21, 2024
Evan Godt

The lead story in Tuesday’s Politico Pulse newsletter will feel familiar to anybody struggling to keep up with the ever-changing AI landscape.

Unfortunately, the subject of this story is the FDA, whose lack of resources to keep up with AI advancement is hindering the agency’s ability to serve its role as regulator.

“Rather than issuing a one-time approval, FDA wants to monitor artificial intelligence products over time, something it’s never done proactively,” writes health-tech reporter Ruth Reader.

Moreover,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Technology
Related Articles:
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients

Share This Article